Identifying patients with myasthenia for epidemiological research by linkage of automated registers

Neuroepidemiology

Volumn 37, Issue 2, 2011, Pages 120-128

  Pedersen, Emil Greve ^a   Hallas, Jesper ^b   Hansen, Klaus ^d   Jensen, Poul Erik Hyldgaard ^d   Gaist, David ^a,c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Epidemiology; Myasthenia; Neurological disorders; Neuromuscular diseases; Research methods

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; PYRIDOSTIGMINE;

ADULT; ARTICLE; AUTOMATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL RESEARCH; MYASTHENIA; PRESCRIPTION; REGISTER;

ADULT; AGED; DENMARK; DRUG PRESCRIPTIONS; FEMALE; HOSPITALS; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; MYASTHENIA GRAVIS; PHARMACOEPIDEMIOLOGY; REGISTRIES;

EID: 80053538450     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000331481     Document Type: Article

References (15)

1. Meriggioli MN, Sanders DB: Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009;8:475-490.
2. Hill M, Ben-Shlomo Y: Neurological care and risk of hospital mortality for patients with myasthenia gravis in England. J Neurol Neurosurg Psychiatry 2008;79:421-425. (Pubitemid 351441499)
3. Alshekhlee A, Miles JD, Katirji B, et al.: Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009;72:1548-1554.
4. Lai C-H, Tseng H-F: Nationwide population-based epidemiological study of myasthenia gravis in Taiwan. Neuroepidemiology 2010;35:66-71.
5. Andersen JB, Engeland A, Owe JF, et al.: Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. Eur J Neurol 2010;17:1445-1450.
6. Christensen PB, Jensen TS, Tsiropoulos I, et al.: Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology 1993;43:1779-1783. (Pubitemid 23307954)
7. Frank L: When an entire country is a cohort. Science 2000;287:2398-2399.
8. Andersen TF, Madsen M, Jørgensen J, et al.: The Danish National Hospital Register: a national source of data for modern health sciences. Dan Med Bull 1999;46:263-268. (Pubitemid 29299976)
9. Gaist D, Sørensen HT, Hallas J: The Danish prescription registries. Dan Med Bull 1997;44:445-448. (Pubitemid 27382061)
10. WHO Collaborating Centre for Drug Statistics Methodology: Anatomical Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs). Oslo, WHO, 2000.
11. Gammeltoft S, Somnier FE: Acetylcholine receptor antibodies in myasthenia gravis: measurements of plasma concentrations by immunoprecipitation. Ugeskr Læger 1984;146:352-355.
12. Kennel PF, Vilquin J-T, Braun S, et al.: Myasthenia gravis: comparative autoantibody assays using human muscle, TE671 and glucocorticoid- treated TE671 cells as sources of antigen. Clin Immunol Immunopathol 1995;74:293-296.
13. Pedersen CB, Gøtzsche H, Møller JØ, et al.: The Danish civil registration system - a cohort of 8 million people. Dan Med Bull 2006;53:441-449. (Pubitemid 44816920)
14. Sørensen HT, Sabroe S, Olsen J: A framework for evaluation of secondary data sources in epidemiological research. Intern J Epidemiol 1996;25:435-442. (Pubitemid 26137126)
15. Grob D, Brunner N, Namba T: Lifetime course of myasthenia gravis. Muscle Nerve 2008;37:141-149. (Pubitemid 351214160)